The Impact of cytochrome P450 2E1-dependent metabolic variance on a risk-relevant pharmacokinetic outcome
Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
| Tag | 1 | 2 | Value |
|---|---|---|---|
| LDR | 00000nab a2200000 i 4500 | ||
| 001 | MAP20071504938 | ||
| 003 | MAP | ||
| 005 | 20080418124434.0 | ||
| 007 | hzruuu---uuuu | ||
| 008 | 040218e20031201usa|||| | |00010|eng d | ||
| 040 | $aMAP$bspa | ||
| 084 | $a873 | ||
| 245 | 1 | 4 | $aThe Impact of cytochrome P450 2E1-dependent metabolic variance on a risk-relevant pharmacokinetic outcome$cJohn C. Lipscomb ... [et al.] |
| 520 | 8 | $aRisk assessment include assumptions about sensitive subpopulations, such as the fraction of the general population that is sensitive and the extent that biochemical or physiological attributes influence sensitivity. Uncertainty factor account for both pharmacokinetic (PK) and pharmacodynamic (PD) components, allowing the inclusin of risk-relevant information to replace default assumptions about PK and PD variance (uncertainty) | |
| 650 | 1 | 1 | $0MAPA20080575083$aCitrocromo P-450 |
| 650 | 1 | 1 | $0MAPA20080537043$aTCP |
| 650 | 0 | 1 | $0MAPA20080576615$aMedicina laboral |
| 650 | 1 | 1 | $0MAPA20080565541$aEpidemiología |
| 650 | 1 | 1 | $0MAPA20080577155$aPlantas químicas |
| 650 | 0 | 1 | $0MAPA20080570484$aRiesgo laboral |
| 700 | 1 | $0MAPA20080198640$aLipscomb, John C. | |
| 773 | 0 | $wMAP20077000345$tRisk analysis : an international journal$dNew York and London : Society for Risk Analysis$gVol. 23, nº 6, December, 2003 ; p. 1221-1238 |